SAMD13 and hepatocellular carcinoma: Since we observed high SAMD13 expression in cisplatin-, sorafenib-, doxorubin- and JNK-28841072 resistant HCC sublines in the GEO database, this suggests that SAMD13 is likely to mediate acquired drug resistance.